Yahoo Web Search

Search results

  1. Aug 23, 2024 · Chikungunya is a mosquito-borne virus that causes fever, joint pain, rash, and other symptoms. Learn about the origins, outbreaks, prevention, and treatment of chikungunya in this comprehensive article.

  2. People also ask

  3. 3 days ago · The epidemiology of chikungunya virus disease is unpredictable; therefore, the high antibody persistence observed at 2 years postvaccination is important, especially for those who frequently travel internationally. A single dose of VLA1553, a live-attenuated chikungunya virus vaccine, resulted in ...

  4. Aug 26, 2024 · chikungunya virus, infectious agent of the genus Alphavirus in the family Togaviridae. The virus causes chikungunya fever, a disease that was first recorded in 1952–53 in an outbreak on the Makonde plateau, located on the border between Mozambique and Tanzania in Africa.

    • Kara Rogers
  5. Sep 2, 2024 · Every month ECDC provides detailed epidemiological overview of the worldwide transmission of chikungunya in its weekly threat report (Communicable Diseases Threat Report).

  6. 4 days ago · Chikungunya virus (CHIKV) is an arbovirus transmitted to humans mainly by Aedes aegypti and Aedes albopictus mosquitoes. CHIKV was first isolated in 1952 in Tanzania and this alphavirus caused ...

  7. Sep 4, 2024 · Chikungunya virus causes an emerging mosquito-borne viral infection that is endemic to much of Latin America, Africa, and south and southeast Asia. Chikungunya is prone to 8–15 year cycles of temporary epidemic expansion, with the last global outbreak in 2014.

  8. Sep 11, 2024 · In November 2023, VLA1553 (Ixchiq; Valneva Austria GmbH) received FDA-approval for chikungunya disease, and was the first vaccine to be approved for this disease. It is indicated for patients who are 18 years and older and are at risk of exposure to chikungunya virus.

  1. People also search for